Augmenting the action of levodopa. (Record no. 4572440)

MARC details
000 -LEADER
fixed length control field 01394 a2200385 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250512113845.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 197304s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0032-5473
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1136/pgmj.48.565.653
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Rao, S K
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19730402
245 00 - TITLE STATEMENT
Title Augmenting the action of levodopa.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Postgraduate medical journal
Date of publication, distribution, etc. Nov 1972
300 ## - PHYSICAL DESCRIPTION
Extent 653-6 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Amantadine
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antacids
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Apomorphine
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carboxy-Lyases
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Catechol O-Methyltransferase Inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dihydroxyphenylalanine
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dopamine beta-Hydroxylase
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Synergism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Methyldopa
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Monoamine Oxidase Inhibitors
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Parasympatholytics
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Parkinson Disease
General subdivision drug therapy
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Vakil, S D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Calne, D B
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hilson, A
773 0# - HOST ITEM ENTRY
Title Postgraduate medical journal
Related parts vol. 48
-- no. 565
-- p. 653-6
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1136/pgmj.48.565.653">https://doi.org/10.1136/pgmj.48.565.653</a>
Public note Available from publisher's website

No items available.